Sickle cell disease trials recruiting in Tennessee

All Sickle cell disease trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• A Long-term Follow-up Study in Patients Who Received BEAM-101
  NCT07373639 · Phase: Not specified · Ages: 14 Years to 37 Years · Sex: All (male and female) · Tennessee: Memphis, Nashville
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Tennessee: Memphis
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Tennessee: Memphis
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
  NCT04398628 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Tennessee: Memphis, Nashville
• Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
  NCT06941389 · Phase: Not specified · Ages: 3 Years to 20 Years · Sex: All (male and female) · Tennessee: Memphis
• Cooperative Assessment of Late Effects for SCD Curative Therapies
  NCT05153967 · Phase: Not specified · Ages: 4 Years to 65 Years · Sex: All (male and female) · Tennessee: Nashville
• Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
  NCT06919224 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Nashville
• Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
  NCT03353584 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 25 Years · Sex: All (male and female) · Tennessee: Memphis
• Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
  NCT05477563 · Phase: Phase 3 · Ages: 12 Years to 35 Years · Sex: All (male and female) · Tennessee: Nashville
• Functional Ovarian Reserve in Sickle Cell Disease
  NCT07392216 · Phase: Not specified · Ages: 10 Years to 18 Years · Sex: Female · Tennessee: Memphis
• Gene Editing For Sickle Cell Disease
  NCT06506461 · Phase: Phase 1 · Ages: 18 Years to 24 Years · Sex: All (male and female) · Tennessee: Memphis
• Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
  NCT05810181 · Phase: Not specified · Ages: 8 Years and older · Sex: All (male and female) · Tennessee: Memphis
• HPC Offered for PRESERVE Expansion
  NCT07145411 · Phase: Not specified · Ages: 12 Years to 80 Years · Sex: All (male and female) · Tennessee: Nashville
• Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
  NCT07616154 · Phase: Phase 2 · Ages: Up to 22 Years · Sex: All (male and female) · Tennessee: Memphis
• Investigation of the Genetics of Hematologic Diseases
  NCT02720679 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Tennessee: Memphis
• Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
  NCT07226219 · Phase: Phase 1 · Ages: 8 Years to 17 Years · Sex: All (male and female) · Tennessee: Memphis
• Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease
  NCT06477289 · Phase: Not specified · Ages: 12 Years to 25 Years · Sex: All (male and female) · Tennessee: Memphis
• Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
  NCT06385886 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Memphis
• Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
  NCT05583721 · Phase: Phase 2 · Ages: 18 Years to 21 Years · Sex: All (male and female) · Tennessee: Memphis
• SCD Stem Cell Mobilization and Apheresis Using Motixafortide
  NCT06442761 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Memphis
• School Readiness Intervention for Preschool Children With Sickle Cell Disease
  NCT06367192 · Phase: Not applicable (e.g. observational or device study) · Ages: 42 Months to 78 Months · Sex: All (male and female) · Tennessee: Memphis
• Sickle Cell Clinical Research and Intervention Program
  NCT02098863 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Tennessee: Memphis
• Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
  NCT04416178 · Phase: Not specified · Ages: 13 Years and older · Sex: All (male and female) · Tennessee: Memphis